October 2023
Anatomic Pathology Market (By Product and Services: Instruments, Consumables, Services; By Application: Disease Diagnosis, Drug Discovery and Development, Others; By End-use: Hospitals, Research Laboratories, Diagnostic Laboratories, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global anatomic pathology market size was valued at USD 32.61 billion in 2023 and is anticipated to reach around USD 75.31 billion by 2033, growing at a CAGR of 8.73% from 2024 to 2033. The anatomic pathology market is driven by the growing dependence on pathology propelled by biomarkers.
The U.S. anatomic pathology market size was estimated at USD 11.01 billion in 2023 and is predicted to be worth around USD 25.59 billion by 2033 with a CAGR of 8.79 from 2024 to 2033.
North America had the dominating share of the anatomic pathology market in 2023. The region is observed to sustain in the market throughout the forecast period. The region consistently introduces state-of-the-art technology in anatomic pathology, including digital pathology systems, improved imaging techniques, and molecular diagnostics, thanks to substantial investments in research and development. These innovations drive the demand for anatomic pathology services in the area, which improve patient outcomes, expedite processes, and increase diagnostic accuracy.
The region's dedication to providing comprehensive healthcare services and encouraging medical innovation is reflected in its high spending on healthcare. An increase in the need for anatomic pathology services is anticipated as healthcare spending rises due to population growth, technology improvements, and healthcare reforms.
Asia-Pacific is observed to be the fastest growing anatomic pathology market during the forecast period. Spending on healthcare has increased in several of the region's growing economies. Governments and private sector entities are devoting more funds to pathology and other healthcare services to improve the need for high-quality healthcare. This investment, which helps develop and expand anatomic pathology services, fuels the market's growth.
The Asia Pacific anatomic pathology market size was calculated at USD 7.17 billion in 2023 and is estimated to cross around USD 16.94 billion by 2033 with a notable CAGR of 8.97% from 2024 to 2033.
Years | Market Size (USD Billion) |
2023 | 7.17 |
2024 | 7.80 |
2025 | 8.48 |
2026 | 9.22 |
2027 | 10.03 |
2028 | 10.90 |
2029 | 11.85 |
2030 | 12.89 |
2031 | 14.01 |
2032 | 15.24 |
2033 | 16.94 |
Anatomic Pathology Market Overview
The area of medicine known as anatomical pathology examines how diseases affect the structural integrity of body organs. Its primary goal is to find anomalies that can aid in disease diagnosis and treatment management. Anatomic pathology uses a microscope to examine tissues and cells to diagnose diseases. These comprise, among many other things, autoimmune illnesses, malignancies, and infectious diseases. A proper diagnosis is necessary to design the best course of treatment.
Anatomic Pathology Market Data and Statistics
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 8.73% |
Global Market Size in 2023 | USD 32.61 Billion |
Global Market Size in 2024 | USD 35.46 Billion |
Global Market Size by 2033 | USD 75.31 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product & Services, By Application, and By End-use |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Drivers
Rising prevalence of cancer
Accurate and quick cancer diagnosis are more in need as cancer incidence rates rise globally. Anatomic pathology is essential to diagnose cancer by analyzing tissue samples from biopsies, surgeries, or other procedures. Anatomic pathology services are in greater demand as more people seek treatment and diagnosis for cancer. Age plays a significant risk factor for many cancer types; the incidence of cancer is predicted to increase as the world's population ages. To correctly identify and treat cancer in aging populations, thorough anatomic pathology services are even more necessary considering this demographic trend.
Up to 5% of instances of colorectal cancer may be caused by the uncommon genetic cancer susceptibility syndrome known as Lynch syndrome. Lynch syndrome raises the risk of colorectal cancer development.
Growing focus on personalized medicine
Anatomic pathology has seen a paradigm shift toward genetic profiling of cancers and other disorders with the introduction of genomic medicine. By examining the genetic composition of malignancies, pathologists can categorize patients into groups according to their molecular profiles, enabling more individualized treatment plans. Molecular profiling, for instance, can be used in cancer to pinpoint specific genetic abnormalities that fuel tumor growth and ultimately lead to the creation of tailored medicines. Personalized medicine can save significant long-term costs by lowering needless treatments, adverse medication responses, and hospitalizations. However, it may initially include more significant upfront expenditures related to molecular diagnostics and tailored therapies.
Restraint
Shortage of skilled professionals
The burden on current employees grows tremendously when there aren't enough skilled people to handle crucial duties like specimen preparation, staining, analysis, and interpretation. Patient care may ultimately suffer from exhaustion, burnout, and a decline in diagnosis precision. Thereby, the shortage of skilled professionals is observed to create a restraint for the anatomic pathology market.
Opportunities
Emerging technologies such as NGS, AI and ML in anatomic pathology
Biomarker analyses have been transformed by next-generation sequencing (NGS), which offers previously unheard-of multiplexing capabilities. In contrast to multiple test ordering required for PCR testing or capillary electrophoresis (CE)–based sequencing (often referred to as Sanger sequencing), NGS may multiplex to assess many genes simultaneously. NGS may help achieve precision medicine's goals of lower costs and better patient care.
It can also help advance prenatal and reproductive care, discover the causative variations of rare and inherited disorders, comprehend the genetic alterations within malignancies, and predict the potential side effects of a chosen medication. By examining the circulating tumor DNA (ctDNA) and, in certain situations, the circulating tumor cells (CTCs) that are present in the blood, NGS is being used to monitor disease.
AI/ML systems are trained to identify patterns in data and link them to clinical contexts, such as diagnoses or outcomes, utilizing predefined input data sets, which may include images. In some instances, they are used to use new data to perform valuable tasks like predicting diagnosis or prognosis.
Recommendations for cancer screening
Cancer screening recommendations generally support routine screenings for members of populations or those with increased risk factors. This causes a spike in the number of screening tests to be carried out, which raises the number of tissue samples that need to be examined pathologically. As a result, there is an increase in the demand for pathology laboratories' services, which presents potential for revenue development and expansion.
The consumables segment dominated the anatomic pathology market in 2023. The foundation of anatomic pathology labs is made up of supplies. Consumables are needed for every step of the diagnostic process, from tissue processing to slide staining and inspection. Because of this, the need for consumables never changes, even in the face of technological advancements or economic downturns. It is frequently renewed. Typically, anatomic pathology labs need customized supplies to fit test protocols or sample kinds. This personalization increases obstacles to entry for new competitors while cultivating client loyalty.
The instruments segment is the fastest growing in the anatomic pathology market during the forecast period. Anatomic pathology is one of the diagnostic services that is in greater demand due to the rising prevalence of chronic diseases like cancer. Accurate and prompt pathology diagnosis is becoming increasingly important as healthcare systems work to enhance patient outcomes and optimize treatment plans. As a result, pathology laboratories are investing in cutting-edge equipment to keep up with the increasing demand for diagnostic services.
The disease diagnosis segment dominated the anatomic pathology market in 2023. Designing a patient's care and course of therapy depends heavily on disease diagnosis. Anatomic pathology is essential for diagnosing illnesses by analyzing tissue samples from biopsies, surgeries, or autopsies. Accurate diagnosis is crucial for choosing the best course of action and keeping track of the condition's advancement. The field of anatomic pathology has been more closely linked to digital health technologies, such as telemedicine platforms and electronic health records (EHRs).
The drug discovery and development segment is observed to grow at the fastest rate during the forecast period. Molecular biology and genetics advances have led to an increasing focus on customized medicine. This paradigm change is greatly aided by anatomic pathology, which offers in-depth molecular insights into each patient's unique characteristics. Regulatory bodies understand how critical it is to support innovation in medication development and discovery to address public health issues.
As a result, laws and incentives have been implemented to expedite the approval process for novel therapies, especially those that aim to treat uncommon diseases or unmet medical needs. The rise in the anatomic pathology segment focused on drug discovery is driven by these regulatory actions that create a favorable environment for investment in research and development.
The hospitals segment dominated the anatomic pathology market in 2023. Hospitals provide care for many patients, from everyday outpatient situations to intricate inpatient situations. Hospitals can maintain high throughput in their pathology laboratories and enhance operational efficiency because of the continual influx of pathology specimens that require examination, which is generated by their diversified patient base. Hospitals benefit from economies of scale that allow them to invest in state-of-the-art technologies, negotiate advantageous price arrangements with vendors, and improve operational workflows for cost-effective pathology services because of their high patient traffic and extensive service offerings.
The diagnostic laboratories segment is the fastest growing anatomic pathology market during the forecast period. The need for cutting-edge diagnostic methods has increased with the introduction of customized medicine, which customizes treatment regimens to each patient's unique traits. Diagnostic laboratories are essential in this paradigm change by providing molecular diagnostics, genetic testing, and companion diagnostics to pinpoint specific biomarkers and direct-focused therapeutics. Diagnostic labs are expected to develop steadily as personalized treatment gains traction.
Segments Covered in the Report
By Product & Services
By Application
By End-use
By Geography
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
October 2023
August 2024
May 2024
June 2024